BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 1660811)

  • 41. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
    Haurum JS; Tan L; Arsequell G; Frodsham P; Lellouch AC; Moss PA; Dwek RA; McMichael AJ; Elliott T
    Eur J Immunol; 1995 Dec; 25(12):3270-6. PubMed ID: 8566011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.
    Feltkamp MC; Vierboom MP; Toes RE; Ossendorp F; ter Schegget J; Melief CJ; Kast WM
    Immunol Lett; 1995; 47(1-2):1-8. PubMed ID: 8537084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carrier-reactive hapten-specific cytotoxic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity.
    Martin S; Ruh H; Hebbelmann S; Pflugfelder U; Rüde B; Weltzien HU
    Eur J Immunol; 1995 Oct; 25(10):2788-96. PubMed ID: 7589073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM; Zhou X; Joki A; Siddiqi AR; Srinivasa BR; Stenvall K; Dahmén J; Jondal M
    Eur J Immunol; 1993 Dec; 23(12):3224-9. PubMed ID: 8258337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density.
    Murray JS; Ferrandis-Edwards D; Wolfe CJ; Schountz T
    Eur J Immunol; 1994 Oct; 24(10):2337-44. PubMed ID: 7925562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
    Abdel-Motal UM; Berg L; Rosén A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmén J; Magnusson G; Karlsson KA; Jondal M
    Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide.
    Staerz UD; Zepp F; Schmid R; Hill M; Rothbard J
    Eur J Immunol; 1989 Dec; 19(12):2191-6. PubMed ID: 2481586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype.
    Murray JS; Pfeiffer C; Madri J; Bottomly K
    Eur J Immunol; 1992 Feb; 22(2):559-65. PubMed ID: 1347015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alloantigen-specific regulation of cytotoxic T cell responses is mediated through the induction of clonal anergy of CD8+ T cells.
    Schutze MP; Langlade-Demoyen P; Leclerc C
    Eur J Immunol; 1992 Feb; 22(2):387-92. PubMed ID: 1531638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions.
    Neefjes JJ; Dierx J; Ploegh HL
    Eur J Immunol; 1993 Apr; 23(4):840-5. PubMed ID: 8384560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fate of the three subunits of major histocompatibility complex class I molecules.
    Neefjes JJ; Smit L; Gehrmann M; Ploegh HL
    Eur J Immunol; 1992 Jun; 22(6):1609-14. PubMed ID: 1318200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
    J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Olsen AC; Pedersen LO; Hansen AS; Nissen MH; Olsen M; Hansen PR; Holm A; Buus S
    Eur J Immunol; 1994 Feb; 24(2):385-92. PubMed ID: 8299688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
    Stuber G; Modrow S; Höglund P; Franksson L; Elvin J; Wolf H; Kärre K; Klein G
    Eur J Immunol; 1992 Oct; 22(10):2697-703. PubMed ID: 1327802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.